Fusion polypeptides and vaccines

作者: Takanori Sato

DOI:

关键词:

摘要: The present invention relates to novel immunogenic polypeptides and their use in vaccine compositions. also nucleic acids,vectors cells which express the uses thereof. of more specifically comprise an domain a cell membrane addressing is derived from B5R gene. particularly suited produce vaccines for non-human animals, vaccinating swine against PCV2 infection.

参考文章(15)
Zoltan Penzes, Ferenc Misák, Attila Csagola, Tamás Tuboly, Novel porcine circovirus type 2b isolate and uses thereof ,(2009)
Anna Kollar, Marianna Ivok, Zoltan Penzes, Synthetic capsid proteins and uses thereof ,(2012)
Michael B. Roof, Gregory Paul Nitzel, Marc Allan Eichmeyer, Phillip Wayne Hayes, Multivalent pcv2 immunogenic compositions and methods of producing such compositions ,(2006)
Hui-xing Lin, Zhe Ma, Hong-jie Fan, Cheng-ping Lu, Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2 Vaccine. ,vol. 30, pp. 6307- 6313 ,(2012) , 10.1016/J.VACCINE.2012.07.082
Heesun Kwak, Waleed Mustafa, Kendra Speirs, Asha J Abdool, Yvonne Paterson, Stuart N Isaacs, Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion. Virology. ,vol. 322, pp. 337- 348 ,(2004) , 10.1016/J.VIROL.2004.02.007